Matches in Nanopublications for { ?s ?p "[The positive clinical experience seen in MDS to date coupled with the persistent challenges faced in the treatment of other hematologic malignancies has served as the impetus for further exploration of the therapeutic value of DNMT inhibitors beyond MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP197797.RAbLZSblEsxXN9ojo-Oq904dU12jgfx2eQ2nruFQm7gw4130_assertion description "[The positive clinical experience seen in MDS to date coupled with the persistent challenges faced in the treatment of other hematologic malignancies has served as the impetus for further exploration of the therapeutic value of DNMT inhibitors beyond MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP197797.RAbLZSblEsxXN9ojo-Oq904dU12jgfx2eQ2nruFQm7gw4130_provenance.
- NP655349.RAqKF8KVkWYwnuFVZtNSqSpD5s9_uFcO9G0tlblsehmb4130_assertion description "[The positive clinical experience seen in MDS to date coupled with the persistent challenges faced in the treatment of other hematologic malignancies has served as the impetus for further exploration of the therapeutic value of DNMT inhibitors beyond MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655349.RAqKF8KVkWYwnuFVZtNSqSpD5s9_uFcO9G0tlblsehmb4130_provenance.
- NP731892.RAnmXLHtHVJOr4WeNW8L0nLdK3jsVOtcRdk6R2encOZzU130_assertion description "[The positive clinical experience seen in MDS to date coupled with the persistent challenges faced in the treatment of other hematologic malignancies has served as the impetus for further exploration of the therapeutic value of DNMT inhibitors beyond MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731892.RAnmXLHtHVJOr4WeNW8L0nLdK3jsVOtcRdk6R2encOZzU130_provenance.
- NP371011.RAPdApPAy6BfrIjkOAti4HOvEcScpxudfE8o2kcRJrdIY130_assertion description "[The positive clinical experience seen in MDS to date coupled with the persistent challenges faced in the treatment of other hematologic malignancies has served as the impetus for further exploration of the therapeutic value of DNMT inhibitors beyond MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP371011.RAPdApPAy6BfrIjkOAti4HOvEcScpxudfE8o2kcRJrdIY130_provenance.
- NP933256.RAG--sMes6dZ3GfSH4x3P-ExHFIxntEPzVheR6VqXZhN4130_assertion description "[The positive clinical experience seen in MDS to date coupled with the persistent challenges faced in the treatment of other hematologic malignancies has served as the impetus for further exploration of the therapeutic value of DNMT inhibitors beyond MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP933256.RAG--sMes6dZ3GfSH4x3P-ExHFIxntEPzVheR6VqXZhN4130_provenance.